Doxapram Use for Apnoea of Prematurity in Neonatal Intensive Care
Apnoea of prematurity is treated with noninvasive respiratory therapy and methylxanthines. For therapy unresponsive apnoea doxapram is often prescibed in preterm neonates. The duration, dosage and route of administration of doxapram together with its efficacy was evaluated in two Dutch neonatal inte...
Saved in:
Main Authors: | S. A. Prins (Author), S. J. A. Pans (Author), M. M. van Weissenbruch (Author), F. J. Walther (Author), S. H. P. Simons (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Precision Dosing of Doxapram in Preterm Infants Using Continuous Pharmacodynamic Data and Model-Based Pharmacokinetics: An Illustrative Case Series
by: Jarinda A. Poppe, et al.
Published: (2020) -
COMPARISON OF THE EFFICIENCY OF CAFFEINE VERSUS AMINOPHYLLINE FOR THE TREATMENT OF APNOEA OF PREMATURITY
by: Gabriela Ildiko Zonda, et al.
Published: (2016) -
Simultaneous Quantification and Pharmacokinetic Characterization of Doxapram and 2-Ketodoxapram in Porcine Plasma and Brain Tissue
by: Manuel Kraft, et al.
Published: (2022) -
Apnoea of Prematurity and Neurodevelopmental Outcomes: Current Understanding and Future Prospects for Research
by: Max Williamson, et al.
Published: (2021) -
PREMATURE BIRTH AND DISEASE PROGRAMMING. CONTRIBUTION OF NEONATAL INTENSIVE CARE
by: O. P. Kovtun, et al.
Published: (2014)